Raloxifene Hydrochloride Tablets IP is a selective estrogen receptor modulator used to help prevent and treat osteoporosis in postmenopausal women and reduce the risk of certain types of invasive breast cancer.
Key Benefits
- Helps maintain bone strength and mineral density
- Supports the prevention and treatment of osteoporosis after menopause
- Helps reduce the risk of vertebral fractures associated with osteoporosis
- May reduce the risk of certain types of invasive breast cancer in appropriate postmenopausal women
- Provides tissue-selective estrogen receptor activity
How It Works
Raloxifene selectively binds to estrogen receptors in different tissues. In bone, it produces estrogen-like effects that help reduce bone loss and maintain bone mineral density. In breast tissue, it blocks estrogen activity, which can help reduce the risk of certain estrogen-dependent breast cancers in selected postmenopausal women.
Common Side Effects
- Hot flashes
- Leg cramps
- Joint or muscle discomfort
- Swelling of the hands, feet, or legs
- Flu-like symptoms
- Increased sweating
Important Information
Raloxifene Hydrochloride Tablets IP should be used under the guidance of a qualified healthcare professional. It is not intended for use during pregnancy and is generally used in postmenopausal women. Raloxifene may increase the risk of serious blood clots, including deep vein thrombosis and pulmonary embolism. Inform your doctor about any history of blood clots or other relevant medical conditions. Seek immediate medical attention for sudden chest pain, shortness of breath, coughing blood, or unexplained leg pain or swelling.